Financial reports
18-K
Annual report (foreign governments)
13 May 24
18-K/A
Annual report (foreign governments) (amended)
22 Mar 24
18-K/A
Annual report (foreign governments) (amended)
7 Feb 24
18-K/A
Annual report (foreign governments) (amended)
9 Nov 23
18-K/A
Annual report (foreign governments) (amended)
10 Aug 23
18-K
Annual report (foreign governments)
11 May 23
18-K/A
Annual report (foreign governments) (amended)
31 Mar 23
18-K/A
Annual report (foreign governments) (amended)
31 Jan 23
18-K/A
Annual report (foreign governments) (amended)
10 Nov 22
18-K/A
Annual report (foreign governments) (amended)
11 Aug 22
Current reports
No filings
Registration and prospectus
424B5
Prospectus supplement for primary offering
19 Apr 24
FWP
Free writing prospectus
17 Apr 24
424B5
Prospectus supplement for primary offering
8 Mar 24
FWP
Free writing prospectus
6 Mar 24
424B5
Prospectus supplement for primary offering
23 Feb 24
FWP
Free writing prospectus
21 Feb 24
FWP
Free writing prospectus
9 Feb 24
424B5
Prospectus supplement for primary offering
11 Jan 24
FWP
Free writing prospectus
9 Jan 24
424B5
Prospectus supplement for primary offering
13 Oct 23
Proxies
No filings
Other
EFFECT
Notice of effectiveness
22 Nov 21
EFFECT
Notice of effectiveness
31 Jul 20
CORRESP
Correspondence with SEC
28 Jul 20
CORRESP
Correspondence with SEC
2 Jul 20
UPLOAD
Letter from SEC
12 Jun 20
EFFECT
Notice of effectiveness
14 May 18
EFFECT
Notice of effectiveness
18 Nov 16
EFFECT
Notice of effectiveness
5 Nov 15
CORRESP
Correspondence with SEC
3 Nov 15
CORRESP
Correspondence with SEC
16 Oct 15
Ownership
SC 13G/A
MAINZ BIOMED N.V.
13 Feb 24
SC 13G
MAINZ BIOMED N.V.
1 Mar 23
SC 13D/A
CureVac N.V.
24 Feb 23
SC 13D/A
CureVac N.V.
13 Feb 23
SC 13D/A
CureVac N.V.
13 Jan 22
SC 13D/A
CureVac N.V.
18 Oct 21
SC 13D/A
CureVac N.V.
1 Feb 21
SC 13D
CureVac N.V.
24 Aug 20
3
American Lorain CORP
14 Sep 16
SC 13D/A
Affimed N.V.
20 Feb 15